NeuroScientific Biopharmaceuticals (ASX:NSB) is a leading Australian biotech company focused on developing novel peptide-based therapeutics for the treatment of neurodegenerative conditions. Our lead drug candidate is a potential first-in-class disease modifying therapeutic, with R&D programs in both CNS and ocular indications.
Ticker:
NSB
Exchange:
ASX
Company Type:
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Australia
Year Founded:
2016
Main Therapeutic Focus:
Lead Product in Development:
EmtinB
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
